NCT04254172 is a clinical trial of Activity Monitor in Duchenne Muscular Dystrophy (DMD), sponsored by Pfizer.

Who is sponsoring NCT04254172?

NCT04254172 is sponsored by Pfizer.

What drugs are being tested in NCT04254172?

Interventions in NCT04254172: Activity Monitor.

What condition does NCT04254172 study?

NCT04254172 studies Duchenne Muscular Dystrophy (DMD).

Is NCT04254172 still recruiting?

NCT04254172 is currently terminated. Last updated 15 October 2021.

Last reviewed 2021-10-15 · How we verify

NCT04254172

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Low Interventional Study to Monitor Activity Using Wearable Sensors in Duchenne Muscular Dystrophy

Terminated Last updated 15 October 2021

What this trial tests

trial testing Activity Monitor in Duchenne Muscular Dystrophy (DMD) in 2 participants. Terminated before completion.

Timeline

19 February 2020

Primary endpoint
19 August 2020

19 August 2020

Quick facts

Lead sponsor	Pfizer
Status	Terminated
Study type	OBSERVATIONAL
Enrollment	2
Start date	19 February 2020
Primary completion	19 August 2020
Estimated completion	19 August 2020
Sites	1 location across United States

Drugs / interventions tested

Activity Monitor

Conditions studied

Duchenne Muscular Dystrophy (DMD) — all drugs for Duchenne Muscular Dystrophy (DMD) →

Sponsor

Pfizer — full company profile →

Who can join

Adults 4 to 12, male only, with Duchenne Muscular Dystrophy (DMD). Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this low interventional study is to collect data on everyday movement in boys with Duchenne muscular dystrophy (DMD) using wearable activity sensors. The activity sensors could provide useful information beyond what is currently collected by functional (movement, strength) assessments in clinic. This information can help with the understanding of the impact of DMD, and perhaps with how possible treatments can affect this impact.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Activity Monitor

Trials testing the same drug.

NCT05498415 — Feasibility, Acceptability, and Efficacy of the Sleep Move Stand Study · NA · completed
NCT05053113 — Utilization of a Peer-Based Approach for the Promotion of Physical Activity in Inactive Women · NA · recruiting
NCT04400903 — Monitoring Heart Rate Variability for the Early Detection of Pancreatic Cancer · terminated
NCT04889131 — Yoga for Seniors · NA · terminated
NCT03971266 — Movement and Fitness Trackers in Determining Performance Status · NA · terminated

Other recruiting trials for Duchenne Muscular Dystrophy (DMD)

Currently open trials in the same condition.

NCT07038824 — A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 45 Skipping to Evaluate the Safety and Efficac · Phase 1, PHASE2 · recruiting
NCT07129954 — Fear of Falling in Muscular Dystrophy · NA · recruiting
NCT07037862 — A Study in Participants With Duchenne Muscular Dystrophy Amenable to Exon 44 Skipping to Evaluate the Safety and Efficac · Phase 1, PHASE2 · recruiting
NCT06755138 — Research on the Relationship Between Scoliosis, Pain, Quality of Life, and Trunk Muscle Compensation Patterns Among Pati · recruiting
NCT06773988 — Follow-up of NIV At Home in Patients with Duchenne Muscular Dystrophy · recruiting

Other Pfizer trials

Trials by the same sponsor.

NCT04982848 — Korea Post Marketing Surveillance (PMS) Study of Talzenna® · not yet recruiting
NCT06873191 — A Study to Learn More About Tukysa Once it is Out in the Korean Market · not yet recruiting
NCT07497854 — A Study to Learn About the Study Medicine NURTEC® ODT 75 mg After it is Released Into the Markets in Korea · not yet recruiting
NCT06507904 — A Study to Learn How Different Preparations of Osivelotor Taste and Enter the Blood With Food or Liquids or With an Anta · Phase 1 · not yet recruiting
NCT06864585 — A Study to Learn About the Study Medicine - Zavicefta in Patients With Sepsis or Loss of Kidney Function in Japan · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04254172 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Pfizer
Last refreshed: 15 October 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04254172.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing